(ethylenedinitrilo)-tetramethylenephosphonic acid has been researched along with Bone Cancer in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deilami-Nezhad, L; Moghaddam-Banaem, L; Sadeghi, M | 1 |
| Ahmad, M; Bhatti, HN; Bokhari, TH; Ghaffar, A; Iqbal, M; Khalid, M; Qadir, MI | 1 |
| Bayouth, JE; Fossella, FV; Kasi, LP; Macey, DJ | 1 |
| Jiang, CY; Zhang, YJ; Zhu, BL | 1 |
| Fordyce, WA; Fossella, FV; Goeckeler, WF; Kasi, LP; Price, DR; Stoneburner, LK | 1 |
| Bernà, L; Cunill, C; Javier Mateos, J; Martín, F; Nadal, C; Ortega, M; Pons, F | 1 |
| Corwin, LA; Ehrhardt, GJ; Goeckeler, WF; Hewett, JE; Ketring, AR; Lattimer, JC; Simon, J; Stapleton, J; Volkert, WA | 1 |
| Willett, CG | 1 |
| Anderson, SK; Corwin, LA; Ehrhardt, GJ; Goeckeler, WF; Ketring, AR; Lattimer, JC; Simon, J; Stapleton, J; Volkert, WA | 1 |
| Burckhardt, P; Leyvraz, S | 1 |
| Farhangi, M; Holmes, RA; Ketring, AR; Singh, A; Stringham, LM; Volkert, WA; Williams, A | 1 |
| Ketring, AR | 1 |
| Holmes, RA; Logan, KW; Volkert, WA | 1 |
2 trial(s) available for (ethylenedinitrilo)-tetramethylenephosphonic acid and Bone Cancer
| Article | Year |
|---|---|
Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases.
Topics: Bone and Bones; Bone Marrow; Bone Neoplasms; Chelating Agents; Humans; Organophosphorus Compounds; Pain; Palliative Care; Radioisotopes; Radionuclide Imaging; Radiotherapy Dosage; Samarium | 1994 |
[The value of Sm-153-EDTMP for treatment of metastatic bone pain and improving quality of life].
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Chelating Agents; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Quality of Life; Radioisotopes; Samarium | 1994 |
11 other study(ies) available for (ethylenedinitrilo)-tetramethylenephosphonic acid and Bone Cancer
| Article | Year |
|---|---|
Development of bone seeker radiopharmaceuticals by Scandium-47 and estimation of human absorbed dose.
Topics: Animals; Bone and Bones; Bone Neoplasms; Drug Stability; Etidronic Acid; Humans; In Vitro Techniques; Ligands; Mice; Organometallic Compounds; Organophosphorus Compounds; Radiation Dosage; Radioisotopes; Radiopharmaceuticals; Scandium; Tissue Distribution | 2017 |
Evaluation of carrier added and no carrier added 90Y-EDTMP as bone seeking therapeutic radiopharmaceutical.
Topics: Animals; Bone Neoplasms; Drug Carriers; Isotope Labeling; Male; Organophosphorus Compounds; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tissue Distribution; Yttrium Radioisotopes | 2014 |
Analysis of urine samples from metastatic bone cancer patients administered 153Sm-EDTMP.
Topics: Bone Neoplasms; Chelating Agents; Chromatography, High Pressure Liquid; Humans; Organophosphorus Compounds; Pain; Radioisotopes; Samarium | 1993 |
[153Sm-EDTMP in a patient suffering from colon cancer with bone metastasis].
Topics: Adenocarcinoma; Adult; Beta Particles; Bone Neoplasms; Cervical Vertebrae; Gamma Rays; Humans; Male; Organophosphorus Compounds; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rectal Neoplasms; Samarium; Scapula; Skull Neoplasms; Spinal Neoplasms | 2001 |
Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs.
Topics: Alkaline Phosphatase; Animals; Bone Marrow; Bone Neoplasms; Dogs; Female; Injections, Intravenous; Leukocyte Count; Male; Organophosphorus Compounds; Radioisotopes; Samarium | 1990 |
Internally administered isotopes in the treatment of solid malignancy.
Topics: Animals; Bone Neoplasms; Dogs; Lung Neoplasms; Microspheres; Organophosphorus Compounds; Phosphorus Radioisotopes; Radioisotopes; Samarium | 1990 |
Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP.
Topics: Animals; Bone Neoplasms; Dog Diseases; Dogs; Drug Administration Schedule; Female; Leukocyte Count; Male; Organophosphorus Compounds; Osteosarcoma; Platelet Count; Radioisotopes; Samarium | 1990 |
Radionuclide targeting of bone metastases: which efficacy?
Topics: Bone Neoplasms; Brachytherapy; Diphosphonates; Humans; Organophosphorus Compounds; Pamidronate; Radioisotopes; Samarium | 1990 |
Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Drug Evaluation; Humans; Male; Middle Aged; Organophosphorus Compounds; Palliative Care; Radioisotopes; Samarium; Tissue Distribution | 1989 |
153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals.
Topics: Animals; Bone Neoplasms; Dogs; Etidronic Acid; Humans; Kinetics; Organophosphorus Compounds; Pain; Rabbits; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Technetium Tc 99m Medronate; Tissue Distribution | 1987 |
Radiation dose calculations in persons receiving injection of samarium-153 EDTMP.
Topics: Animals; Bone Neoplasms; Chelating Agents; Energy Transfer; Humans; Mathematics; Organophosphorus Compounds; Radiation Dosage; Radioisotopes; Rats; Samarium; Tissue Distribution | 1987 |